These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 15273650)

  • 1. The use of pharmacotherapy in the prodrome of schizophrenia.
    Remington G; Shammi C
    CNS Spectr; 2004 Aug; 9(8):579-86. PubMed ID: 15273650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychosis treatment prior to psychosis onset: ethical issues.
    McGlashan TH
    Schizophr Res; 2001 Aug; 51(1):47-54. PubMed ID: 11479065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beating psychosis to the punch: the treatment options debate.
    Gorman JM
    CNS Spectr; 2004 Aug; 9(8):572. PubMed ID: 15273647
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of the schizophrenia prodrome: is it presently ethical?
    Cornblatt BA; Lencz T; Kane JM
    Schizophr Res; 2001 Aug; 51(1):31-8. PubMed ID: 11479063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toward a better identification and treatment of schizophrenia prodrome.
    Bota RG; Sagduyu K; Filin EE; Bota DA; Munro S
    Bull Menninger Clin; 2008; 72(3):210-27. PubMed ID: 18990056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Dilemma of early drug intervention in prepsychotic illnesses of adolescence].
    Branik E; Meng H
    Prax Kinderpsychol Kinderpsychiatr; 2003 Dec; 52(10):751-65. PubMed ID: 14699785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The diagnosis and assessment of individuals prodromal for schizophrenic psychosis.
    Addington J
    CNS Spectr; 2004 Aug; 9(8):588-94. PubMed ID: 15273651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early intervention for schizophrenia: the risk-benefit ratio of antipsychotic treatment in the prodromal phase.
    Weiser M
    Am J Psychiatry; 2011 Aug; 168(8):761-3. PubMed ID: 21813489
    [No Abstract]   [Full Text] [Related]  

  • 9. Prodromal schizophrenia: the dilemma of prediction and early intervention.
    Davidson M; Weiser M
    CNS Spectr; 2004 Aug; 9(8):578. PubMed ID: 15273649
    [No Abstract]   [Full Text] [Related]  

  • 10. First vs multiple episode schizophrenia: two-year outcome of intermittent and maintenance medication strategies.
    Gaebel W; Jänner M; Frommann N; Pietzcker A; Köpcke W; Linden M; Müller P; Müller-Spahn F; Tegeler J
    Schizophr Res; 2002 Jan; 53(1-2):145-59. PubMed ID: 11728846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early intervention in schizophrenia: current and future perspectives.
    Keshavan MS; Amirsadri A
    Curr Psychiatry Rep; 2007 Aug; 9(4):325-8. PubMed ID: 17880865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identifying vulnerability markers in prodromal patients: a step in the right direction for schizophrenia prevention.
    Knowles L; Sharma T
    CNS Spectr; 2004 Aug; 9(8):595-602. PubMed ID: 15273652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Symptom assessment in schizophrenic prodromal states.
    Miller TJ; McGlashan TH; Woods SW; Stein K; Driesen N; Corcoran CM; Hoffman R; Davidson L
    Psychiatr Q; 1999; 70(4):273-87. PubMed ID: 10587984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of acute treatment response in patients with a first episode of non-affective psychosis: sociodemographics, premorbid and clinical variables.
    Crespo-Facorro B; Pelayo-Terán JM; Pérez-Iglesias R; Ramírez-Bonilla M; Martínez-García O; Pardo-García G; Vázquez-Barquero JL
    J Psychiatr Res; 2007 Oct; 41(8):659-66. PubMed ID: 16797591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proceedings and data from The Schizophrenia Summit: a critical appraisal to improve the management of Schizophrenia.
    Nasrallah HA; Keshavan MS; Benes FM; Braff DL; Green AI; Gur RE; Kane JM; Perkins DO; Weiden PJ; Weinberger DR; Correll CU
    J Clin Psychiatry; 2009; 70 Suppl 1():4-46. PubMed ID: 19292973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ethical issues in early-intervention clinical trials involving minors at risk for schizophrenia.
    DeGrazia D
    Schizophr Res; 2001 Aug; 51(1):77-86. PubMed ID: 11479069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ethics of the early intervention in the treatment of schizophrenia.
    Filaković P; Degmecić D; Koić E; Benić D
    Psychiatr Danub; 2007 Sep; 19(3):209-15. PubMed ID: 17914322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective observations of emerging psychosis.
    Rosen JL; Woods SW; Miller TJ; McGlashan TH
    J Nerv Ment Dis; 2002 Mar; 190(3):133-41. PubMed ID: 11923647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The risk-benefit ratio of the proposed DSM-5 attenuated psychosis syndrome.
    Woods SW; McGlashan TH
    Am J Psychiatry; 2011 Dec; 168(12):1338; author reply 1338. PubMed ID: 22193675
    [No Abstract]   [Full Text] [Related]  

  • 20. Commentary: The schizophrenia prodrome: a high-risk concept.
    Yung AR
    Schizophr Bull; 2003; 29(4):859-65. PubMed ID: 14989420
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.